Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$250.72M
Total Bought
$41.51M
Total Sold
$4.95M
Net Transaction
+$36.55M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
GRACELL BIOTECHNOLOGIES INC01,375,000+1,375,00003,9601.58%+3,960
IO BIOTECH INC0864,197+864,19701,2190.49%+1,219
VAXCYTE INC(PCVX)793,036793,036039,60440,42916.13%+825
ALIGOS THERAPEUTICS INC743,215743,21507225550.22%-166
BOLT BIOTHERAPEUTICS INC1,891,4671,891,46702,4211,9670.78%-454
EXSCIENTIA PLC770,500770,50004,5613,4831.39%-1,079
INOZYME PHARMA INC3,661,5184,494,851+833,33320,39518,8787.53%-1,516
VIGIL NEUROSCIENCE INC560,595560,59505,2703,0221.21%-2,248
FUSION PHARMACEUTICALS INC1,560,9821,560,98207,2904,0591.62%-3,231
ARCUTIS BIOTHERAPEUTICS INC(ARQT)1,105,3091,105,309010,5345,8692.34%-4,664
OCULIS HOLDING AG2,381,1962,218,754-162,44229,36024,4069.73%-4,954
RALLYBIO CORP2,404,6442,404,644013,6108,1043.23%-5,507
KARUNA THERAPEUTICS INC782,008797,008+15,000169,578134,76653.75%-34,812
Page 1 of 1